2013-10-28T14:57:08-05:00 2012-12-31 453269313 YH ADVISORS INC 7755 CENTER AVENUE SUITE 1225 HUNTINGTON BEACH CA 92647 990 2012-01-01 261636099 MELANOMA RESEARCH ALLIANCE FOUNDATION MELA 2023368935 1101 NEW YORK AVE NW NO 620 WASHINGTON DC 20005 WENDY SELIG 2023368935 2013-10-22 1 BRIAN YACKER P00401346 3109822806 2012 2016-03-07 17:11:31Z WENDY SELIG 1101 NEW YORK AVE NW NO 620 WASHINGTON DC 20005 9310702 0 X WWW.CUREMELANOMA.ORG X 2007 DE TO ACCELERATE SCIENTIFIC DISCOVERY TO ELIMINATE SUFFERING AND DEATH DUE TO MELANOMA 17 16 9 50 0 0 21013477 8538768 0 0 21414 84485 0 0 21034891 8623253 5103877 7431733 0 0 710511 923393 0 0 485653 842050 913143 6656438 9268269 14378453 -645016 31331243 30877458 349687 540918 30981556 30336540 X TO ACCELERATE THE PACE OF SCIENTIFIC DISCOVERY, ULTIMATELY TO FIND A CURE BY FUNDING THE MOST PROMISING MELANOMA RESEARCH WORLDWIDE THAT WILL IMPROVE THE OUTCOME FOR PATIENTS AND ALL WHO ARE AT RISK 0 0 8407573 7431733 THE MELANOMA RESEARCH ALLIANCE FOUNDATION ("MRA") SUPPORTS AMBITIOUS AND INNOVATIVE PROJECTS, INITIATED BY INDIVIDUAL SCIENTISTS AND SCIENCE RESEARCH TEAMS, TO DEVELOP NOVEL DIAGNOSTIC AND THERAPEUTIC AVENUES RELEVANT TO PATHWAYS GOVERNING THE BEHAVIOR AND CLINICAL OUTCOME OF MELANOMA. MRA CONVENES A WORLD CLASS, CROSS-DISCIPLINARY GROUP OF EXPERT BIOMEDICAL RESEARCHERS POSSESSING CLINICAL AND SCIENTIFIC EXPERTISE TO DEVELOP A RESEARCH AGENDA THAT WILL PROVIDE INNOVATIVE SOLUTIONS TO CRITICAL RESEARCH ISSUES LEADING TO BETTER TREATMENTS AND A CURE FOR MELANOMA. MRA MAKES GRANTS TO DOMESTIC RESEARCH UNIVERSITIES, MEDICAL SCHOOLS, AND NONPROFIT MEDICAL RESEARCH ORGANIZATIONS DIRECTLY INVOLVED IN DETERMINING THE CAUSES AND CURES OF MELANOMA ON THE CONDITION THAT SUCH RESEARCH BE MADE AVAILABLE TO THE SCIENTIFIC COMMUNITY. MRA ALSO MAKES GRANTS TO FOREIGN RESEARCH UNIVERSITIES, MEDICAL SCHOOLS AND MEDICAL RESEARCH ORGANIZATIONS. 8407573 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 1 1 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 1 X 23 0 1 9 1 0 0 0 0 0 1 1 0 0 0 0 X 17 16 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 AL AK AZ AR CA CO CT FL GA HI IL KS KY MA MD ME MI MN NH NJ NM NY NC ND PA OR OK OH RI SC TN UT VA WA WI WV X X KAMYAB HASHEMI-NEJAD 3105704612 1250 FOURTH STREET SANTA MONICA CA 90401 DEBRA BLACK 20.00 X X 0 0 0 LEON BLACK 0.30 X 0 0 0 MARIA BELL 0.30 X 0 0 0 ELLEN DAVIS 0.30 X 0 0 0 JASON FEDERICI 0.30 X 0 0 0 JAMI GERTZ 0.30 X 0 0 0 SUSAN HESS 0.30 X 0 0 0 MICHAEL KLOWDEN 0.30 40.00 X 0 488627 16887 CONNIE MACK 0.30 X 0 0 0 NANCY MARKS 0.30 X 0 0 0 MICHAEL MILKEN 0.30 X 0 0 0 RICHARD RESSLER 0.30 X 0 0 0 JEFFREY ROWBOTTOM 0.30 X 0 0 0 GREGORY SIMON 0.30 X 0 0 0 JONATHAN SIMONS 0.30 X 0 0 0 JONATHAN SOKOLOFF 0.30 X 0 0 0 ELIZABETH STANTON 0.30 X 0 0 0 WENDY SELIG 40.00 X 280531 0 19313 KAMYAB HASHEMI-NEJAD 10.00 40.00 X 0 160894 15317 LAUREN LEIMAN 40.00 X 153218 0 14448 LAURA BROCKWAY-LUNARDI 40.00 X 103061 0 7344 536810 649521 73309 3 0 1 0 0 4666666 3872102 245100 8538768 29985 29985 554500 500000 54500 54500 54500 187449 4666666 187449 0 8623253 0 0 84485 6815067 6815067 616666 616666 299845 119938 59969 119938 512867 215015 146979 150873 66908 26010 16953 23945 43773 17947 11381 14445 4478 3039 358 1081 17500 17500 205987 174734 11500 19753 44624 23254 7383 13987 15801 6513 4010 5278 110319 61101 21435 27783 153362 61888 39069 52405 83902 27434 9018 47450 235117 231809 356 2952 7676 3147 1996 2533 9786 4011 2545 3230 CREDIT CARD PROCESSING 12615 12615 STATE FILING FEES 11976 11976 9268269 8407573 375043 485653 3333239 2720777 6999554 8240917 20439692 19806654 8274 80424 41162 13884 6109 27278 544375 1408 31331243 30877458 139051 169505 70000 50000 140636 321413 349687 540918 X 9760006 9392604 21221550 20943936 30981556 30336540 31331243 30877458 -645016 0 X 0 1 X 1 0 X X X X 0 0 0 THE MILKEN INSTITUTE 954240775 7 1 1 1 7431733 1 7431733 SCHEDULE A, PART IV, SUPPLEMENTAL INFORMATION: SCHEDULE A, PART I, LINE 11(H)A THE AMOUNT OF SUPPORT REPORTED TO MILKEN INSTITUTE REPRESENTS THE AMOUNT OF FUNDS THAT MRA PAYS DIRECTLY TO RESEARCH ORGANIZATIONS LISTED ON SCHEDULES F AND I THAT SUPPORT MELANOMA RESEARCH THAT ADVANCES THE MISSION OF BOTH MRA AND THE MILKEN INSTITUTE. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 2500 2500 8892722 8895222 594761 148690 0 0 592013 469731 594761 1656505 2484758 4500 7500 2500 14500 148003 117433 148690 414126 621189 41162 13884 27278 27278 DUE TO MILKEN INSTITUTE/FASTERCURES 321413 321413 8692431 69178 69178 8623253 0 8623253 9337447 69178 69178 9268269 0 9268269 1 NORTH AMERICA 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 341666 EAST ASIA AND THE PACIFIC 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 150000 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 75000 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 50000 0 0 0 0 0 0 616666 0 616666 EAST ASIA AND THE PACIFIC ESTABLISHED INVESTIGATOR AWARD 100000 CHECK EAST ASIA AND THE PACIFIC PILOT AWARD 50000 CHECK NORTH AMERICA TEAM SCIENCE AWARD 300000 CHECK NORTH AMERICA YOUNG INVESTIGATOR AWARD 41666 CHECK MIDDLE EAST AND NORTH AFRICA YOUNG INVESTIGATOR AWARD 50000 CHECK EUROPE (INCLUDING ICELAND & GREENLAND) YOUNG INVESTIGATOR AWARD 75000 CHECK 6 0 0 0 0 0 0 0 PROCEDURE FOR MONITORING GRANTS OUTSIDE THE U.S.: SCHEDULE F, PART I, LINE 2: EACH PROPOSAL TO THE MRA IS REVIEWED FOR SCIENTIFIC MERIT AND TRANSLATIONAL AND CLINICAL IMPACT BY MRA'S WORLD-CLASS GRANT REVIEW COMMITTEE (GRC). CRITERIA ARE DESCRIBED IN THE MRA'S REQUEST FOR PROPOSALS. GRC MEMBERS ARE SENIOR THOUGHT-LEADERS IN MELANOMA AND CANCER RESEARCH. AFTER SCIENTIFIC PEER REVIEW BY THE GRC, THE MRA BOARD OF DIRECTORS APPROVES FINAL RESEARCH AWARDS FOR FUNDING. RESEARCH AWARD FUNDS ARE DISPENSED ON AN ANNUAL BASIS, CONTINGENT UPON MRA STAFF REVIEW OF ANNUAL PROGRESS REPORTS SUBMITTED BY THE GRANTEES. METHOD USED TO ACCCOUNT FOR EXPENDITURES: SCHEDULE F, PART I, LINE 3: AWARDEES PROVIDE MRA WITH ANNUAL WRITTEN REPORTS OF THEIR RESEARCH PROGRESS AND COMPLIANCE WITH BUDGET GUIDELINES. FUNDS ARE DISTRIBUTED IN ANNUAL INSTALLMENTS AND NEXT YEAR'S INSTALLMENT IS NOT PROVIDED UNTIL SATISFACTORY REVIEW BY THE MRA CHIEF SCIENCE OFFICER AND SCIENTIFIC PROGRAM DIRECTOR. AWARDEES MUST KEEP SYSTEMATIC AND COMPLETE RECORDS ON THE RECEIPT AND DISBURSEMENT OF ALL AWARD FUNDS, AND MAY NOT COMMINGLE ANY FUNDS FROM OTHER SOURCES. ANNUAL DINNER 4055026 3995517 59509 13592 32918 12999 LEVEREDGED FINANCE 799089 671149 127940 65278 47820 14842 4854115 4666666 187449 78870 80738 27841 187449 0 1 CASE WESTERN RESERVE UNIVERSITY - SCHOOL OF MEDICINE 10900 EUCLID AVENUE CLEVELAND OH 44106 341018992 500 (C) (3) 75000 YOUNG INVESTIGATOR AWARD CHILDREN'S HOSPITAL BOSTON 300 LONGWOOD AVENUE BOSTON MA 02115 042774441 501 (C) (3) 300000 TEAM SCIENCE AWARD CLEVELAND CLINIC FOUNDATION 9500 EUCLID AVENUE CLEVELAND OH 44195 340714585 501 (C) (3) 50000 PILOT AWARD COLD SPRING HARBOR LABORATORY 1 BUNGTOWN RD COLD SPRING HARBOR NY 11724 112013303 501 (C) (3) 200000 TEAM SCIENCE AWARD COLUMBIA UNIVERSITY MEDICAL CENTER ICRC 402A 1130 ST NICHOLAS AVE NEW YORK NY 10032 135598093 501 (C) (3) 75000 YOUNG INVESTIGATOR AWARD DANA-FARBER CANCER INSTITUTE 450 BROOKLINE AVE BOSTON MA 02115 042263040 501 (C) (3) 450000 TEAM SCIENCE AWARD; ESTABLISHED INVESTIGATOR AWARDS DUKE UNIVERSITY 2200 MAIN STREET DURHAM NC 27705 560532129 501 (C) (3) 125000 ESTABLISHED INVESTIGATOR AWARD ENTERTAINMENT INDUSTRY FOUNDATION 1201 WEST 5TH STREET SUITE T-700 LOS ANGELES CA 90017 951644609 501 (C) (3) 1000000 SU2C/MRA MELANOMA DREAM TEAM FRED HUTCHINSON CANCER RESEARCH CENTER 100 FAIRVIEW AVE N SEATTLE WA 98109 237156071 501 (C) (3) 175000 TEAM SCIENCE AWARD GEORGETOWN UNIVERSITY 3970 RESERVOIR ROAD NW RESEARCH BUILDING ROOM E501 WASHINGTON DC 20016 530196603 501 (C) (3) 125000 ESTABLISHED INVESTIGATOR AWARD H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE 12902 MAGNOLIA DRIVE TAMPA FL 33612 592451713 501 (C) (3) 333334 TEAM SCIENCE AWARD HENRY FORD HEALTH SYSTEM 1 FORD PLACE 1D27 DETROIT MI 48202 381357020 501 (C) (3) 75000 YOUNG INVESTIGATOR AWARD JOHNS HOPKINS UNIVERSITY 1550 ORLEANS STREET BALTIMORE MD 21205 520595110 501 (C) (3) 575000 TEAM SCIENCE AWARD; YOUNG INVESTIGATOR AWARD MASSACHUSETTS GENERAL HOSPITAL (THE GENERAL HOSPITAL CORP) 149 13TH STREET CHARLESTOWN MA 02129 042697983 501 (C) (3) 75000 YOUNG INVESTIGATOR AWARD MEMORIAL SLOAN-KETTERING CANCER INSTITUTE 1275 YORK AVENUE NEW YORK NY 10021 131924236 501 (C) (3) 1158332 YOUNG INVESTIGATOR AWARDS; ESTABLISHED INVESTIGATOR PARTNERSHIP AWARD; ESTABLISHED INVESTIGATOR AWARDS; TEAM SCIENCE AWARD NEW YORK UNIVERSITY 550 FIRST AVE NEW YORK NY 10116 135562308 501 (C) (3) 216668 TEAM SCIENCE AWARD; PILOT AWARD ROCKEFELLER UNIVERSITY 1230 YORK AVENUE BOX 16 NEW YORK NY 10065 131624158 501 (C) (3) 274960 ESTABLISHED INVESTIGATOR AWARD; YOUNG INVESTIGATOR AWARD SAINT LOUIS UNIVERSITY 1100 S GRAND BLVD EDWARD A DOISY RESEARCH CENTER 8TH FLOOR ST LOUIS MO 63104 430654872 501 (C) (3) 75000 YOUNG INVESTIGATOR AWARD SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE 10901 N TORREY PINES ROAD LA JOLLA CA 92037 510197108 501 (C) (3) 100000 ESTABLISHED INVESTIGATOR TRUSTEES OF BOSTON UNIVERSITY B U MEDICAL CAMPUS 72 EAST CONCORD STREET K-712C BOSTON MA 02118 042103547 501 (C) (3) 100000 ESTABLISHED INVESTIGATOR AWARD TRUSTEES OF DARTMOUTH COLLEGE ONE MEDICAL CENTER DR LEBANON NH 03756 020222111 501 (C) (3) 50000 DEVELOPMENT AWARD UNIVERSITY OF CALIFORNIA LOS ANGELES 11000 KINROSS AVE STE 102 LOS ANGELES CA 90095 956006143 PUBLIC UNIVERSITY 391668 TEAM SCIENCE AWARD; ESTABLISHED INVESTIGATOR AWARD; PILOT AWARD; YOUNG INVESTIGATOR AWARD UNIVERSITY OF CALIFORNIA SAN FRANCISCO DILLER CANCER RESEARCH BUILDING 1450 3RD STREET HD-365 SAN FRANCISCO CA 94158 946036493 PUBLIC UNIVERSITY 250000 TEAM SCIENCE AWARD; ESTABLISHED INVESTIGATOR AWARD UNIVERSITY OF CHICAGO 5801 S ELLIS AVE CHICAGO IL 60637 362177139 501 (C) (3) 125000 ESTABLISHED INVESTIGATOR UNIVERSITY OF PENNSYLVANIA PERELMAN CENTER FOR ADVANCED MEDICINE 3400 CIVIC CENTER BOULEVAR PHILADELPHIA PA 19104 231352685 501 (C) (3) 50000 PILOT AWARD UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE BLVD UNIT 1374 HOUSTON TX 77030 174601118 PUBLIC UNIVERSITY 100000 TEAM SCIENCE AWARD; ESTABLISHED INVESTIGATOR AWARD UNIVERSITY OF VIRGINIA PO BOX 800334 HOSPITAL WEST 6171 E BOX 800334 CHARLOTTESVILLE VA 22908 412097394 PUBLIC UNIVERSITY 140976 TEAM SCIENCE AWARDS; YOUNG INVESTIGATOR AWARD; ESTABLISHED INVESTIGATOR PARTNERSHIP AWARD WASHINGTON UNIVERSITY IN ST LOUIS 660 SOUTH EUCLID AVENUE ST LOUIS MO 63110 430653611 501 (C) (3) 50000 ESTABLISHED INVESTIGATOR AWARD YALE UNIVERSITY 47 COLLEGE ST NEW HAVEN CT 06520 060646973 501 (C) (3) 100000 DEVELOPMENT AWARD; ESTABLISHED INVESTIGATOR AWARD 29 29 PROCEDURE FOR MONITORING GRANTS IN THE U.S.: PART I, LINE 2: SCHEDULE I, PART I, LINE 2: EACH PROPOSAL TO THE MRA IS REVIEWED FOR SCIENTIFIC MERIT AND TRANSLATIONAL AND CLINICAL IMPACT BY MRA'S WORLD-CLASS GRANT REVIEW COMMITTEE (GRC). CRITERIA ARE DESCRIBED IN THE MRA'S REQUEST FOR PROPOSALS. GRC MEMBERS ARE SENIOR THOUGHT-LEADERS IN MELANOMA AND CANCER RESEARCH. AFTER SCIENTIFIC PEER REVIEW BY THE GRC, THE MRA BOARD OF DIRECTORS APPROVES FINAL RESEARCH AWARDS FOR FUNDING. RESEARCH AWARD FUNDS ARE DISPENSED ON AN ANNUAL BASIS, CONTINGENT UPON MRA STAFF REVIEW OF ANNUAL PROGRESS REPORTS SUBMITTED BY THE GRANTEES. ALL MRA-FUNDED INVESTIGATORS AND THEIR INSTITUTIONS MUST AGREE TO PERFORM THE RESEARCH PROPOSAL IN FULL COMPLIANCE WITH ALL APPLICABLE LAWS AND REGULATIONS, THE TERMS AND CONDITIONS OF THE MRA REQUEST FOR PROPOSALS, THE REQUIREMENTS OF THE MRA TERMS AND CONDITIONS OF THE RESEARCH PROPOSAL. AT ANY TIME DURING THE AWARD PERIOD, AWARDEES MUST NOTIFY AND MRA MUST APPROVE ANY SIGNIFICANT CHANGES TO THE RESEARCH PROPOSAL INCLUDING RESEARCH PLAN, BUDGET, AND PERSONNEL. AWARDEES PROVIDE MRA WITH ANNUAL WRITTEN REPORTS OF THEIR RESEARCH PROGRESS AND COMPLIANCE WITH BUDGET GUIDELINES. FUNDS ARE DISTRIBUTED IN ANNUAL INSTALLMENTS AND NEXT YEAR'S INSTALLMENT IS NOT PROVIDED UNTIL SATISFACTORY REVIEW BY THE MRA CHIEF SCIENCE OFFICER AND SCIENTIFIC PROGRAM DIRECTOR. AWARDEES MUST KEEP SYSTEMATIC AND COMPLETE RECORDS ON THE RECEIPT AND DISBURSEMENT OF ALL AWARD FUNDS, AND MAY NOT CO-MINGLE ANY FUNDS FROM OTHER SOURCES. X X X 0 0 0 0 0 0 0 0 0 MICHAEL KLOWDEN 0 388627 0 100000 0 0 0 2450 0 14437 0 505514 0 0 WENDY SELIG 250531 0 30000 0 0 0 2450 0 16863 0 299844 0 0 0 KAMYAB HASHEMI-NEJAD 0 155894 0 5000 0 0 0 1669 0 13648 0 176211 0 0 LAUREN LEIMAN 149218 0 4000 0 0 0 0 0 14448 0 167666 0 0 0 PART I, LINE 3 ACCORDING TO THE MRA BYLAWS, MEMBERS OF THE BOARD REVIEW AND APPROVE THE MRA'S CEO SALARY TO ENSURE IT IS JUST AND REASONABLE. DURING THIS ANNUAL REVIEW, MEMBERS OF THE BOARD USE THE FEDERAL FORM 990 OF OTHER ORGANIZATIONS FOR COMPARABLES. X 1 245100 PROCEEDS (SEC SALES) 0 0 1 0 METHOD FOR DETERMINING NUMBER OF CONTRIBUTORS: PART I, COLUMN (B): THE "NUMBER OF CONTRIBUTORS REPORTED" ON SCHEDULE M ARE THE NUMBER OF SEPARATE CONTRIBUTIONS OF SECURITIES RECEIVED BY MRA. W-2 EMPLOYEES FORM 990, PART V, LINE 2A THE ORGANIZATION DOES NOT ISSUE ANY W-2S FOR THEIR EMPLOYEES. THE SUPPORTED ORGANIZATION, THE MILKEN INSTITUTE ISSUES ALL W-2S BUT EMPLOYEE COMPENSATION IS PAID BY THE MELANOMA RESEARCH ALLIANCE ITSELF. W-2S REPORTED ARE THOSE THAT ARE ISSUED BY MILKEN ON BEHALF OF MRA. FORM 990, PART VI, SECTION A, LINE 2 DEBRA BLACK AND LEON BLACK HAVE A FAMILY RELATIONSHIP. DEBRA BLACK AND RICHARD RESSLER HAVE A FAMILY RELATIONSHIP. JAMI GERTZ AND DEBRA BLACK HAVE A FAMILY RELATIONSHIP. FORM 990, PART VI, SECTION B, LINE 11 MRA'S CEO AND TREASURER JOINTLY REVIEW THE FORM 990. THE FINAL DRAFT IS MADE AVAILABLE ELECTRONICALLY TO ALL THE BOARD MEMBERS BEFORE THE CEO SIGNS THE DOCUMENT AND FILES IT WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C AS STATED IN THE MRA BYLAWS, EACH DIRECTOR, TRUSTEE, PRINCIPAL OFFICER, AND MEMBER OF A COMMITTEE OF THE BOARD IS TO SIGN A STATEMENT ANNUALLY AFFIRMING THEY HAVE RECEIVED THE CONFLICT OF INTEREST POLICY, THEY HAVE READ AND UNDERSTAND IT, AND THEY AGREE TO COMPLY WITH IT. UPON POTENTIAL CONFLICT OF INTERESTS, THE BOARD OR COMMITTEE WILL RESOLVE THE CONFLICT IN THE BEST INTEREST OF THE ORGANIZATION. FORM 990, PART VI, SECTION B, LINE 15A ACCORDING TO THE MRA BYLAWS, MEMBERS OF THE BOARD REVIEW AND APPROVE THE MRA CEO SALARY TO ENSURE IT IS JUST AND REASONABLE. DURING THIS ANNUAL REVIEW, MEMBERS OF THE BOARD USE THE FEDERAL FORM 990 OF OTHER ORGANIZATIONS FOR COMPARABLES. THERE ARE NO OTHER OFFICERS, DIRECTORS, OR KEY EMPLOYEES THAT ARE COMPENSATED BY MRA. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. A COPY OF THE FORM 990 AND THE FINANCIAL STATEMENTS ARE AVAILABLE ON THE ORGANIZATION'S WEBSITE. MILKEN INSTITUTE 1250 FOURTH STREET SANTA MONICA CA 90401 954240775 EDUCATIONAL, ECONOMIC RESEARCH, HEALTHCARE RESEARCH CA 501(C)(3) LINE 7 N/A 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 MILKEN INSTITUTE K 137070 RENTAL EXPENSE PER SUBLEASE MILKEN INSTITUTE P 783694 CASH TRANSFERRED TO REIMBURSE EXP